TickerFacts.

Polyrizon Ltd. (PLRZ): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

-$4.54M
Year ended 2025-12-31
2022-12-31: -$1.14M2025-12-31: -$4.54M-$4.54M
2022-12-31 Free Cash Flow (USD) 2025-12-31
Period endedFree Cash FlowChange YoYSource filing
2025-12-31-$4.54Mn/a2026-03-25, From 2025-01-01
No annual figure between 2022-12-31 and 2025-12-31.
2022-12-31-$1.14Mn/a2025-03-11, From 2022-01-01

Free Cash Flow at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedFree Cash FlowChange YoY
Polyrizon Ltd. (PLRZ)2025-12-31-$4.54Mn/a
Femasys Inc (FEMY)2025-12-31-$19.22Mn/m
PolyPid Ltd. (PYPD)2025-12-31-$28.09Mn/m
INVO Fertility, Inc. (IVF)2025-12-31-$7.06Mn/m
Co-Diagnostics, Inc. (CODX)2025-12-31-$29.84Mn/m
Vivos Therapeutics, Inc. (VVOS)2025-12-31-$17.60Mn/m
Cerenome, Inc. (CNSY)2025-12-31-$20.84Mn/m
KORU Medical Systems, Inc. (KRMD)2025-12-31-$470.1Kn/m
Catheter Precision, Inc. (VTAK)2025-12-31-$8.31Mn/m

Compare PLRZ, FEMY, PYPD, IVF side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗